Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer

Author： Caffo O.   Fellin G.   Graffer U.   Valduga F.   Bolner A.   Luciani L.   Tomio L.   Galligioni E.  

Publisher： Elsevier

ISSN： 0360-3016

Source： International Journal of Radiation Oncology*Biology*Physics, Vol.57, Iss.5, 2003-12, pp. : 1310-1316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Intra-operative electron radiotherapy as a conservative treatment for infiltrating bladder cancer

By Rostom Y.A.   Chapet O.   Russo S.M.   Dubernard P.   Marechal J.M.   Sentenac I.   Gilly F.N.   Gerard J.P.  

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1781-1787

Elsevier

Access to resources Recommend Favorite

What is the available evidence to support immediate adjuvant intravesical chemotherapy after transurethral resection of superficial transitional cell carcinoma of the bladder? - Phase III study of intravesical instillation of epirubicin, BCG tice and BCG tice plus isoniazid in intermediate and high risk TaT1 papillary carcinoma of the bladder

By Schellhammer P.F.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 3, 1998-05 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

A Phase I/II Trial of Radiotherapy Concurrent with TS-1 Plus Cisplatin in Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205

By Imano Motohiro   Furukawa Hiroshi   Yokokawa Masaki   Nishimura Yasumasa   Kurokawa Yukinori   Satoh Taroh   Sakai Daisuke   Yasuda Takushi   Imamoto Haruhiko   Tujinaka Toshimasa   Shimokawa Toshio   Shiozaki Hitoshi  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 431-435

Oxford University Press

Access to resources Recommend Favorite

Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study

By Togawa Akira   Yoshitomi Hideyuki   Ito Hiroshi   Kimura Fumio   Shimizu Hiroaki   Ohtsuka Masayuki   Yoshidome Hiroyuki   Kato Atsushi   Sawada Shigeaki   Miyazaki Masaru  

International Journal of Clinical Oncology, Vol. 12, Iss. 4, 2007-08 ,pp. : 268-273

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study

By Belpomme D.   Krakowski I.   Beauduin M.   Petit T.   Canon J.L.   Janssens J.   Gauthier S.   De Pauw A.   Moreau V.   Kayitalire L.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 32-38

Elsevier

Access to resources Recommend Favorite